Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Zippelius

Showing results (81-90 of 163) with videos related to

Pageof 17
Sort By:
Molecular Therapy. Methods & Clinical Development|March 5, 2021
iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapyDominik Brücher, Nicole Kirchhammer, Sheena N Smith, et al.
Melanoma Research|October 31, 2018
Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter studyJoshua Z Drago, Donald Lawrence, Elisabeth Livingstone, et al.
Plos One|August 23, 2016
Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer MedicineChristian Ruiz, Stefan Kustermann, Elina Pietilae, et al.
Cancer Research|September 3, 2004
High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanomaNorbert Meidenbauer, Alfred Zippelius, Mikaël J Pittet, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2006
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patientsAlfred Zippelius, Asma Gati, Tammo Bartnick, et al.
The Journal of Experimental Medicine|February 21, 2002
Thymic selection generates a large T cell pool recognizing a self-peptide in humansAlfred Zippelius, Mikaël J Pittet, Pascal Batard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Human thymus exports naive CD8 T cells that can home to nonlymphoid tissuesAlfred Zippelius, Gilles Bioley, Frédérique-Anne Le Gal, et al.
Science Translational Medicine|November 27, 2015
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockadePhilipp Müller, Matthias Kreuzaler, Tarik Khan, et al.
Science Advances|June 30, 2023
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapyOmar S Sarkar, Howard Donninger, Numan Al Rayyan, et al.
The Journal of Pathology|September 1, 2019
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancerIlaria Alborelli, Katharina Leonards, Sacha I Rothschild, et al.
Pageof 17

Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
Molecular Therapy. Methods & Clinical Development|March 5, 2021
iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapyDominik Brücher, Nicole Kirchhammer, Sheena N Smith, et al.
Melanoma Research|October 31, 2018
Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter studyJoshua Z Drago, Donald Lawrence, Elisabeth Livingstone, et al.
Plos One|August 23, 2016
Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer MedicineChristian Ruiz, Stefan Kustermann, Elina Pietilae, et al.
Cancer Research|September 3, 2004
High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanomaNorbert Meidenbauer, Alfred Zippelius, Mikaël J Pittet, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2006
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patientsAlfred Zippelius, Asma Gati, Tammo Bartnick, et al.
The Journal of Experimental Medicine|February 21, 2002
Thymic selection generates a large T cell pool recognizing a self-peptide in humansAlfred Zippelius, Mikaël J Pittet, Pascal Batard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Human thymus exports naive CD8 T cells that can home to nonlymphoid tissuesAlfred Zippelius, Gilles Bioley, Frédérique-Anne Le Gal, et al.
Science Translational Medicine|November 27, 2015
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockadePhilipp Müller, Matthias Kreuzaler, Tarik Khan, et al.
Science Advances|June 30, 2023
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapyOmar S Sarkar, Howard Donninger, Numan Al Rayyan, et al.
The Journal of Pathology|September 1, 2019
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancerIlaria Alborelli, Katharina Leonards, Sacha I Rothschild, et al.
Pageof 17